Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Sleep-disordered Breathing
66%
Sleep Disorders
48%
Obstructive Sleep Apnea
47%
Sleep Apnea
41%
Sleep Medicine
37%
Plasma Concentration
33%
Dementia with Lewy Bodies
33%
Vascular Biomarkers
33%
Milestones 2.0
33%
Home Testing
33%
Pre-stroke
33%
Cardiovascular Consequences
33%
Inflammatory Biomarkers
33%
Glymphatic System
33%
Sleep Quality
33%
Hospitalized Patients
33%
COVID-19
33%
Perivascular Spaces
33%
Sleep Assessment
33%
Obstructive Sleep Apnea Patient
33%
Post-stroke
33%
Neuromuscular Disorders
33%
Probable Dementia
27%
Home Sleep Apnea Test
25%
Patient Care
23%
Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD)
22%
Accreditation Council for Graduate Medical Education (ACGME)
20%
Home Environment
16%
Current Guidelines
16%
Home Sleep Study
16%
Interstitial Laser
16%
Angiopoietin
14%
Congestive Heart Failure
13%
Hypertension
13%
Coronary Artery Disease
13%
Quality of Life
13%
Patient Comfort
13%
Noninvasive Ventilation
13%
Disease Progression
11%
Patient-centered
11%
Neuroimmune Process
11%
Neocortical
11%
PDGFA
9%
Newly Diagnosed
9%
White Matter Hyperintensities
9%
Neurofilament Light (NF-L)
9%
CXCL10
9%
Sleep Disturbance
8%
Daytime Sleepiness
8%
Hospitalization
8%
Neuroscience
Obstructive Sleep Apnea
100%
Sleep Disorder
90%
Positron Emission Tomography
33%
Mesial Temporal Lobe Epilepsy
33%
Dementia with Lewy Bodies
33%
Anterior Temporal Lobectomy
33%
Quality of Sleep
33%
Neuroimmunology
33%
Cerebrovascular Accident
33%
Blood Plasma
33%
Biological Marker
33%
Magnetic Resonance Imaging
33%
Glymphatic System
33%
Rapid Eye Movement Sleep
19%
Behavior Disorder
19%
Central Nervous System
16%
Platelet-Derived Growth Factor
11%
Magnetic Resonance Imaging of Brain
11%
Angiopoietin 1
11%
Neuropsychological Assessment
11%
Amygdalohippocampectomy
11%
Daytime Somnolence
8%
Sleep Quality
8%
Autoimmune Disease
8%
Neurofilament Light Chain
7%
CXCL10
7%
Cognitive Disorders
6%
Imaging Technique
6%
Adenosine
6%
Aquaporin 4
6%
Astrocyte
6%
Neurodegenerative Disorder
6%
